Get started
Author

Muhammad Umar Afzal

Observed names: Afzal, Muhammad Umar, M Afzal, Majid Afzal, Raja Majid Afzal
Observed institutions: University of Copenhagen, Mayo Clinic, Copenhagen University Hospital, Gentofte Hospital, Rigshospitalet, Mayo Clinic in Arizona, Mayo Clinic Hospital, Mayo Clinic Comprehensive Cancer Center (Arizona)
ORCID: 0000-0002-3904-9122
Observed ORCID: 0000-0002-3904-9122
OpenAlex ID: A5101418828
The impact of consanguinity on the frequency of inborn errors of metabolism
2018 · Raja Majid Afzal, Allan Meldgaard Lund, et al. · Molecular Genetics and Metabolism Reports · 39
MatchMiner-AI: Open-source, Privacy-preserving Cancer Clinical Trial Matching using Artificial Intelligence
2024 · Altreuter, Jennifer, Trukhanov, Pavel, et al. · arXiv (Cornell University) · 5
PDF
Trials on Timing of Cardiovascular Medication Administration
2025 · Manan Pareek, Niklas Dyrby Johansen, et al. · JACC Advances · 2
Disparities in guideline-concordant treatment receipt for localized prostate cancer (PCa): A SEER-based analysis.
2025 · Salman Ayub Jajja, Umair Ayub, et al. · Journal of Clinical Oncology · 1
High-sensitivity troponin-T concentrations and long-term risk of death in patients with acute pulmonary embolism
2023 · M Pareek, V Rosberg, et al. · European Heart Journal · 1
PDF
Abstract C004: Understanding survivorship needs to inform development of the iCCaRE ViRA AI Survivorship Platform for black prostate cancer survivors
2026 · Opeyemi Bolajoko, Ewan Kemar Cobran, et al. · Cancer Epidemiology Biomarkers & Prevention
Abstract A176: Low utilization of the Decipher genomic classifier and oncologic outcomes in African American men with localized prostate cancer: A cancer-disparities analysis
2026 · Kaneez Zahra R. Khakwani, Muhammad Ali Khan, et al. · Cancer Epidemiology Biomarkers & Prevention
Abstract B056: Comparative efficacy of definitive radiotherapy and radical prostatectomy in African American men with high-risk and very high-risk prostate cancer: A real-world institutional cohort study
2026 · Muhammad Umar Afzal, Ewan Kemar Cobran, et al. · Cancer Epidemiology Biomarkers & Prevention
Improving automated prostate cancer risk assessment: An ensemble LLM framework for clinical T-stage inference and NCCN risk stratification.
2026 · Umair Ayub, Syed Arsalan Ahmed Naqvi, et al. · Journal of Clinical Oncology
Hybrid AI framework for automated prostate cancer disease state ascertainment from real-world electronic health records.
2026 · Umair Ayub, Syed Arsalan Ahmed Naqvi, et al. · Journal of Clinical Oncology
Impact of GLP1 receptor agonists on severity of prostate cancer at diagnosis: A propensity score weighted analysis.
2026 · Muhammad Ali Khan, Viraj R. Shah, et al. · Journal of Clinical Oncology
Comparative real-world survival and prescription patterns of darolutamide versus apalutamide in non-metastatic hormone-resistant prostate cancer.
2026 · Muhammad Umar Afzal, Lanyu Mi, et al. · Journal of Clinical Oncology
PDF
Utilization of bone modifying agents in metastatic hormone resistant prostate cancer: A retrospective study of real world patients.
2026 · Yashveer Chohan, Naif A. Ganadily, et al. · Journal of Clinical Oncology
Sociodemographic predictors of the late-stage diagnosis in patients with prostate cancer: A retrospective cohort study.
2025 · Muhammad Ali Khan, Muhammad Umar Afzal, et al. · Journal of Clinical Oncology
Works count: 14
Citation count: 48
H-index: 2
I10-index: 1
Year
Topic
Type